Jpmorgan Chase & Co »

Acelyrin shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $24M 3.2M 7.46
2023-09-30 $32M 3.2M 10.17
2023-06-30 $77M 3.7M 20.90